Cancer Immunology Grants

Irvington Institute Fellowship Program of the Cancer Research Institute

The Irvington Institute Fellowship Program of the Cancer Research Institute (formerly called the Cancer Research Institute Postdoctoral Fellowship Program), established in 1971, is our longest-standing continuous program to support and train young immunologists at top universities and research centers.

Over the past 38 years, 968 young scientists have received postdoctoral fellowship awards from CRI, including two who later won the Nobel Prize. In 2007, following the merger of the Cancer Research Institute and the Irvington Institute for Immunological Research, the program was renamed after the Irvington Institute to reflect the considerable value of Irvington's assets, all of which have been directed into the postdoctoral fellowship program. As a result, CRI increased the number and level of fellowship awards it makes each year, effective in fiscal year 2008.

The Institute has funded 998 fellows since 1971, two of whom have gone on to win the Nobel Prize, and many others who now fill top scientific positions at universities and medical centers around the world.

Within the framework of this program, the Institute is able to provide the brightest young scientists the means to embark on a career in immunology research. Our fellows have different research interests and conduct their work in laboratories around the world, but they all support the Institute's driving mission to conquer cancer through immunology by increasing our understanding of the human immune system. Mentored by some of the world’s leading immunologists, these young researchers bring fresh insight and enthusiasm to their work, receiving postgraduate training while carrying out the seminal research that can lead to the next wave of major discoveries in the field.

Fellowship candidates are rigorously evaluated by a panel of 23 members of our Scientific Advisory Council. The selection is highly competitive and is based on the qualifications and experience of both the applicant and the proposed sponsor, as well as the nature and feasibility of the intended line of inquiry and the overall training environment.

Deadlines for application are April 1 and October 1 annually. Fellowship appointments are for three years, with graded stipends at $45,000 for the first year, $47,000 for the second, and $49,000 for the third. A yearly allowance of $1,500 is provided to the host institution to help meet expenses for research supplies, travel to scientific meetings, and health insurance incurred on behalf of the fellow. Fellows are encouraged to attend CRI’s annual symposium, where they have an opportunity to present posters of their research while interacting with world-leaders in both basic and clinical cancer immunology. CRI fellows have made numerous contributions to the peer-reviewed scientific publications that advance our understanding of the immune system and its relationship to cancer.

Phone
1-800-99CANCER or 1-800-992-2623
(212) 688-7515
9 a.m. and 5 p.m. Eastern Time weekdays

Fax
(212) 832-9376

Mail
Cancer Research Institute
National Headquarters
One Exchange Plaza
55 Broadway, Suite 1802
New York, NY 10006

Questions about our research funding programs should be directed to grants@cancerresearch.org.

Irvington Institute Fellowship Program of the Cancer Research Institute

The Irvington Institute Fellowship Program of the Cancer Research Institute (formerly called the Cancer Research Institute Postdoctoral Fellowship Program), established in 1971, is our longest-standing continuous program to support and train young immunologists at top universities and research centers.

Over the past 38 years, 968 young scientists have received postdoctoral fellowship awards from CRI, including two who later won the Nobel Prize. In 2007, following the merger of the Cancer Research Institute and the Irvington Institute for Immunological Research, the program was renamed after the Irvington Institute to reflect the considerable value of Irvington's assets, all of which have been directed into the postdoctoral fellowship program. As a result, CRI increased the number and level of fellowship awards it makes each year, effective in fiscal year 2008.

The Institute has funded 998 fellows since 1971, two of whom have gone on to win the Nobel Prize, and many others who now fill top scientific positions at universities and medical centers around the world.

Within the framework of this program, the Institute is able to provide the brightest young scientists the means to embark on a career in immunology research. Our fellows have different research interests and conduct their work in laboratories around the world, but they all support the Institute's driving mission to conquer cancer through immunology by increasing our understanding of the human immune system. Mentored by some of the world’s leading immunologists, these young researchers bring fresh insight and enthusiasm to their work, receiving postgraduate training while carrying out the seminal research that can lead to the next wave of major discoveries in the field.

Fellowship candidates are rigorously evaluated by a panel of 23 members of our Scientific Advisory Council. The selection is highly competitive and is based on the qualifications and experience of both the applicant and the proposed sponsor, as well as the nature and feasibility of the intended line of inquiry and the overall training environment.

Deadlines for application are April 1 and October 1 annually. Fellowship appointments are for three years, with graded stipends at $45,000 for the first year, $47,000 for the second, and $49,000 for the third. A yearly allowance of $1,500 is provided to the host institution to help meet expenses for research supplies, travel to scientific meetings, and health insurance incurred on behalf of the fellow. Fellows are encouraged to attend CRI’s annual symposium, where they have an opportunity to present posters of their research while interacting with world-leaders in both basic and clinical cancer immunology. CRI fellows have made numerous contributions to the peer-reviewed scientific publications that advance our understanding of the immune system and its relationship to cancer.

Phone
1-800-99CANCER or 1-800-992-2623
(212) 688-7515
9 a.m. and 5 p.m. Eastern Time weekdays

Fax
(212) 832-9376

Mail
Cancer Research Institute
National Headquarters
One Exchange Plaza
55 Broadway, Suite 1802
New York, NY 10006

Questions about our research funding programs should be directed to grants@cancerresearch.org.

Society for Hematology and Stem Cells Travel Grants to ISEH 2010 Meeting

Date: 15 - 18 September, 2010

Location: Melbourne Convention & Exhibition Centre, Melbourne Australia (www.mcec.com.au/)

Through the generous support of the State government of Victoria we are able to offer up to 200 travel grants for PhD students and post-doctoral delegates as follows:

Delegates traveling from Europe AUD$2000
Delegates traveling from the USA AUD$1500
Delegates traveling from Asia AUD$1200
Delegates traveling from New Zealand or within Australia AUD$300

Applications need to be submitted with your abstract and will be assessed based on the abstract rankings. Travel award applicants must also include a letter from their Mentor/Supervisor with their abstract submission requesting travel support and identifying need. *You must be an ISEH member to apply for a travel grant.

Key Dates:

* Registration /Abstract Submission Open; March 1, 2010
* Abstract Submissions Close: May 1, 2010
* Travel Grant Requests Close: May 1, 2010
* Early Bird Registration Closes: June 1, 2010

The Society for Hematology and Stem Cells (ISEH) was established in 1950 by a group of scientists who sought to create a forum for the presentation and discussion of pre-clinical data in experimental hematology. ISEH continues to be dedicated to the promotion of the scientific knowledge and clinical application of basic hematologic and immunologic disorders through research, publications, and scientific programs. Incorporated in 1972 in the USA, the Society has over 800 active members from 40 countries around the world. Its annual scientific meeting attracts more than 500 participants over 4 days and, together with its official monthly journal Experimental Hematology, provides essential delivery of quality education, training programs, discussion forums, as well as promotes basic research.

Knowledge
Offering comprehensive programs and publications in training and education, ISEH membership provides the tools for expansive understanding and cutting-edge methodologies from around the globe.

Innovation
Providing the latest scientific information, ISEH members are at the forefront of advances in experimental hematology including:

* Progenitor cells, hematopoiesis, growth factors and cytokines
* Immunology
* Mechanisms of hematologic malignancies (leukemias, lymphomas, myelomas)
* Oncology
* Oncogenes
* Stem Cell niches
* Cancer stem cells
* Gene profiling (microarray chips) and protein chips
* Stem cell biology and transplantation (bone marrow, peripheral blood, cord blood)
* Cellular therapy
* Gene therapy
* Hematopoietic microenvironment

For more information on how to apply for these grants contact ISEH@marqueemarketing.com.au

ISEH
401 N. Michigan Ave, Ste 2400
Chicago, IL 60611 USA
Phone: (+1/202) 367-1183
Fax: (+1/202) 367-2183
E-mail: info@iseh.org